Tumour necrosis factor antagonists are superior to anti-integrin and anti-IL-12/23 therapies for preventing postoperative recurrence in adult Crohn's disease patients requiring postoperative therapy

被引：0
|
作者：
Nakamura, T. [1 ]
Shah, R. [2 ]
Sachs, M. [3 ]
Chang, S. [4 ]
Hudesman, D. [4 ]
Click, B. [5 ]
Axelrad, J. [4 ]
机构：
[1] NYU, Med Ctr, Med, New York, NY 10016 USA
[2] Cleveland Clin, Med Ctr, Med, Cleveland, OH 44106 USA
[3] Karolinska Inst, Clin Epidemiol, Solna, Sweden
[4] NYU, Med Ctr, Gastroenterol & Hepatol, New York, NY 10016 USA
[5] Cleveland Clin, Med Ctr, Gastroenterol Hepatol & Nutr, Cleveland, OH 44106 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P502
引用
收藏
页码：S436 / S437
页数：2
相关论文
共 41 条
  • [1] TUMOR NECROSIS FACTOR ANTAGONISTS ARE SUPERIOR TO ANTI-INTEGRIN AND ANTI-IL-12/23 THERAPIES FOR PREVENTING POSTOPERATIVE RECURRENCE IN ADULT CROHN'S DISEASE PATIENTS REQUIRING POSTOPERATIVE THERAPY
    Nakamura, Takahiro I.
    Shah, Ravi S.
    Chauhan, Kirtan
    Sachs, Michael
    Chang, Shannon
    Hudesman, David
    Click, Benjamin H.
    Regueiro, Miguel D.
    Axelrad, Jordan E.
    GASTROENTEROLOGY, 2020, 158 (06) : S924 - S926
  • [2] Tumor Necrosis Factor Antagonists Are Superior to Ustekinumab and Vedolizumab for the Prevention of Postoperative Recurrence in Adult Crohn's Disease
    Nakamura, Takahiro
    Main, Michael
    Chang, Shannon
    Click, Benjamin
    Hudesman, David
    Axelrad, Jordan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S384 - S384
  • [3] Serious infection in patients with Crohn's disease newly treated with anti-integrin and anti-tumour necrosis factor agents: A real-world study
    Afzali, A.
    Song, X.
    Shi, N.
    Skup, M.
    Lee, W. -J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S226 - S226
  • [4] RISK OF POSTOPERATIVE COMPLICATIONS AMONG INFLAMMATORY BOWEL DISEASE PATIENTS TREATED PREOPERATIVELY WITH ANTI-INTEGRIN AND ANTI-TUMOR NECROSIS FACTOR AGENTS
    Yamada, Akihiro
    Komaki, Yuga
    Patel, Nayan
    Komaki, Fukiko
    Pekow, Joel R.
    Dalal, Sushila
    Cohen, Russell D.
    Cannon, Lisa
    Umanskiy, Konstantin
    Smith, Radhika
    Hurst, Roger
    Hyman, Neil
    Rubin, David T.
    Sakuraba, Atsushi
    GASTROENTEROLOGY, 2017, 152 (05) : S574 - S574
  • [5] Factors associated with anti-tumor necrosis factor effectiveness to prevent postoperative recurrence in Crohn's disease
    Buisson, Anthony
    Cannon, Lisa
    Umanskiy, Konstantin
    Hurst, Roger D.
    Hyman, Neil H.
    Sakuraba, Atsushi
    Pekow, Joel
    Dalal, Sushila
    Cohen, Russell D.
    Pereira, Bruno
    Rubin, David T.
    INTESTINAL RESEARCH, 2022, 20 (03) : 303 - +
  • [6] Remission of refractory Crohn's disease with anti-IL-12/23 therapy in a patient undergoing hemodialysis: A case report
    Spathakis, Michail
    Filidou, Eirini
    Kolios, George
    Papazoglou, Dimitrios
    Vradelis, Stergios
    HEMODIALYSIS INTERNATIONAL, 2023, 27 (03) : E41 - E44
  • [7] Systematic Review with Meta-analysis of Prospective Studies: Anti-tumour Necrosis Factor for Prevention of Postoperative Crohn's Disease Recurrence
    Qiu, Yun
    Mao, Ren
    Chen, Bai-li
    He, Yao
    Zeng, Zhi-rong
    Chen, Min-hu
    JOURNAL OF CROHNS & COLITIS, 2015, 9 (10): : 918 - 927
  • [8] Stopping anti-tumour necrosis factor therapy in patients with perianal Crohn's disease
    Mak, Joyce Wing Yan
    Tang, Whitney
    Yip, Terry Cheuk Fung
    Ran, Zhi Hua
    Wei, Shu Chen
    Ahuja, Vineet
    Kumar, Sudheer
    Leung, Wai Keung
    Hilmi, Ida
    Limsrivilai, Julajak
    Aniwan, Satimai
    Lam, Belsy C. Y.
    Chan, Kam Hon
    Ng, Ka Man
    Leung, Chi Man
    Li, Michael K. K.
    Lo, Fu Hang
    Sze, Alex Shun Fung
    Tsang, Steven Woon Choy
    Hui, Aric J.
    Hartono, Juanda Leo
    Ng, Siew C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (11-12) : 1195 - 1203
  • [9] EARLY INITIATION OF ANTI-TUMOR NECROSIS FACTOR THERAPY REDUCES POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE FOLLOWING ILEOCECAL RESECTION
    Axelrad, Jordan E.
    Li, Terry
    Nakamura, Takahiro
    Bachour, Salam P.
    Shah, Ravi S.
    Sachs, Michael
    Chang, Shannon
    Hudesman, David
    Holubar, Stefan D.
    Cohen, Benjamin L.
    Rieder, Florian
    Lightner, Amy L.
    Esen, Eren
    Barnes, Edward L.
    Remzi, Feza H.
    Regueiro, Miguel D.
    Click, Benjamin
    GASTROENTEROLOGY, 2022, 162 (07) : S183 - S184
  • [10] The Impact of Anti-Tumor Necrosis Factor Alpha Therapy on Postoperative Complications in Pediatric Crohn's Disease
    Dotlacil, Vojtech
    Bronsky, Jiri
    Hradsky, Ondrej
    Frybova, Barbora
    Coufal, Stepan
    Skaba, Richard
    Rygl, Michal
    EUROPEAN JOURNAL OF PEDIATRIC SURGERY, 2020, 30 (01) : 27 - 32
12345